Sun Pharma shares in focus after Q4 profit drops 19% YoY to Rs 2,154 crore



Sun Pharmaceuticals shares are expected to be in focus on Friday after the company reported a 19% year-on-year decline in consolidated net profit for the March quarter, which fell to ₹2,154 crore from ₹2,659 crore in the same period last year.

Comments